Рет қаралды 2,971
Peter Ratcliffe is a physician scientist who trained in medicine at Gonville and Caius College, Cambridge and St. Bartholomew's Hospital, London, before moving to Oxford to specialise in renal medicine.
After studying the physiology of renal circulation, he became interested in the regulation of the haematopoietic growth factor erythropoietin, which is produced by the kidneys in response to reduced blood oxygen availability, and in 1989, he set up the Hypoxia Biology Laboratory at Oxford.
His work on oxygen sensing has won a number of awards including the Louis-Jeantet Prize in Medicine, the Canada Gairdner International Award, and the Lasker Award for Basic Biomedical Research.
Peter was elected to the Fellowship of the Royal Society and to the Academy of Medical Sciences in 2002. He is a member of EMBO and a foreign honorary member of the American Academy of Arts and Sciences.
He was knighted for services to medicine in the New Year's Honours, 2014.
In 2004, he was appointed Nuffield Professor of Clinical Medicine at the University of Oxford and served as Head of the Nuffield Department of Clinical Medicine from 2004-2016.
In May 2016 he was appointed Director of Clinical Research at the Francis Crick Institute, retaining a position at Oxford as member of the Ludwig Institute of Cancer Research and Director of Oxford's Target Discovery Institute.